All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
The oxidized form of the cytochrome c heme group can accept an electron from the heme group of the cytochrome c1 subunit of cytochrome reductase. Cytochrome c then transfers this electron to the cytochrome oxidase complex, the final protein carrier in the mitochondrial electron-transport chain.
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-C157Z | Chimeric anti-MCC peptide T cell receptor (2B4), pCDTCR1 | Manduca sexta | 2B4 | Chimeric | ADLIAYLKQATKG | I-Ek | Lentiviral | |
TCR-C158Z | Chimeric anti-MCC peptide T cell receptor (226), pCDTCR1 | Manduca sexta | 226 | Chimeric | ADLIAYLKQATKG | I-Ek | Lentiviral |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION